• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    COMPREHENSIVE HEALTHCARE SYSTEMS ANNOUNCES APPOINTMENT OF NEW BOARD MEMBER AND CHIEF EXECUTIVE OFFICER

    1/25/22 8:00:00 AM ET
    $CERN
    $GE
    $MCK
    Managed Health Care
    Health Care
    Consumer Electronics/Appliances
    Technology
    Get the next $CERN alert in real time by email

    CALGARY, AB, Jan. 25, 2022 /CNW/ - Comprehensive Healthcare Systems Inc. (TSXV:CHS) (the "Company" or "CHS"), an industry leader in Healthcare Benefits Administration software and services, is pleased to announce the appointment of Chris Cosgrove as the Company's new President and Chief Executive Officer ("CEO") and to its board of directors effective February 1, 2022.  Mr. Cosgrove has 25 years of management and leadership experience in the healthcare technology industry and will replace CHS founder, Dr. Hassan Mohaideen, who will continue in his role as Chairman of the board of directors (the "Board") and be appointed Chief Medical Officer of the Company.

    "With a proven track record of leading and growing healthcare technology businesses, Chris is uniquely qualified to carry on our mission to streamline the way consumers navigate their healthcare," said Dr. Mohaideen. "He shares our values and vision and will continue to build upon everything that sets CHS apart. It's been an honor founding and building CHS, and I'm looking forward to working with Chris as we scale the company and grow the impact of CHS's NOVUS platform across the care continuum."

    The board of directors believe that the appointment of Mr. Cosgrove is a pivotal step towards building an institutional-grade sales focused commercial organization to ramp up sales and add new clients. A key focus area for the incoming CEO will be to target federal, state, and local governments in providing solutions to rising healthcare costs and to facilitate transparency in costs and administration. CHS's management and the board of directors believe that organic revenue growth, launching new telehealth solutions (such as for the mental health space) and focusing on strategic acquisitions will be key priority areas for CHS during 2022.

    Chris Cosgrove

    Mr. Cosgrove has been a leader and innovator in healthcare IT for over 30 years. Having worked at both Fortune 100 and early-stage companies, he has extensive experience driving company growth, product value and building high performing teams.

    Mr. Cosgrove's most recent role was Market President of Welltok's Provider Business, a leading healthcare consumer engagement company. Mr. Cosgrove and the team focused on growth and product innovation that ultimately positioned Welltok as a leader in the healthcare data analytics and patient engagement space. Prior to Welltok, he also served as EVP/GM of Vitals, a company focused on patient engagement and transparency, where he led the growth and development of new solutions into the Provider Healthcare Market. Prior to Vitals, Mr. Cosgrove held leadership positions at McKesson Provider Technologies (NYSE:MCK), Cerner Corporation (NASDAQ:CERN) and GE Healthcare (NYSE:GE).

    "With what's going on in the world today, it's never been more important to help consumers understand, navigate and manage their healthcare," Cosgrove said.  "I'm honored to be named CHS's CEO as we work to deliver innovation and value for our customers, helping to streamline the management of benefits for consumers, employers and providers. CHS has the ideal combination of compelling cloud-based offerings, with proven client deployments and a great experienced team.  I believe that CHS's core product can be the industry leader. It is flexible, cost effective, efficient and can be sold to a far wider market. The growth and enhancement of the sales capabilities will be my key priority and I'm excited about what we can accomplish, building off tremendous market growth."

    Pursuant to the employment agreement entered into between Mr. Cosgrove and the Company, CHS has granted Mr. Cosgrove options to acquire up to 500,000 common shares in the capital of CHS (each a "Share"), at an exercise price of $0.45 per Share, and vesting schedule of three years. (the "Stock Options").

    About Comprehensive Healthcare Systems Inc.

    Comprehensive Healthcare Systems Inc. is a corporation incorporated under the laws of the Province of Alberta and is the parent company of Comprehensive Healthcare Systems Inc. (Delaware). The Company is a vertically integrated software as a services (SaaS) company focused on digitizing healthcare with Telehealth and Healthcare Benefits Administration solutions, providing reliable and high-volume transaction capable systems. The Company's state of the art HPS Novus Healthcare Welfare and Benefits Administration (HWBA) SaaS platform is used by clients for all aspects of healthcare benefit administration (including insurance companies, hospitals, doctors and labor unions, through various corporation in which the majority shareholder has controlling ownership), providing healthcare administrative software, licensing and maintenance services.

    Forward-Looking Statements

    Forward-Looking Information

    This news release contains certain "forward-looking information" and "forward-looking statements" (collectively referred to as "forward-looking statements"). These forward-looking statements relate to future events or the Company's future performance. All statements other than statements of historical fact are forward-looking statements. Often, but not always, forward-looking statements can be identified by the use of words such as "plans", "expects", "is expected", "budget", "scheduled", "estimates", "continues", "forecasts", "projects", "predicts", "intends", "anticipates" or "believes", or variations of, or the negatives of, such words and phrases, or state that certain actions, events or results "may", "could", "would", "should", "might" or "will" be taken, occur or be achieved. Particularly, information regarding our expectations of future results, targets, performance achievements, prospects or opportunities is forward-looking information. Forward-looking statements in this news release include, but may not be limited to, statements about the potential growth of the Company's product to become a future leader./

    Forward-looking statements are based on management's assumptions as at the date the forward-looking statements are provided, including assumptions regarding: the Company's management ability to execute its business strategy. Though management believes that its assumptions are reasonable in the circumstances, forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the Company's actual results, performance, or achievements to differ materially from all or any of the future results, performance or achievements expressed or implied by forward-looking statements. Risk factors that could cause the Company's actual results, performance, or achievements to differ from the forward-looking statements in this news release include but may not be limited to: the inability of the Company's management to execute its business strategy, adverse or unexpected changes to regulatory regimes related to the medical industry, and general market and economic risks. Accordingly, readers should not place undue reliance on forward-looking statements.

    The Company undertakes no obligation to update these forward-looking statements, other than as required by applicable law.

    Neither the TSX Venture Exchange nor its Regulation Service Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

    SOURCE Comprehensive Healthcare Systems Inc.

    Cision View original content: http://www.newswire.ca/en/releases/archive/January2022/25/c3409.html

    Get the next $CERN alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CERN
    $GE
    $MCK

    CompanyDatePrice TargetRatingAnalyst
    GE Aerospace
    $GE
    5/27/2026$375.00Buy
    Seaport Research Partners
    McKesson Corporation
    $MCK
    4/28/2026Outperform
    William Blair
    GE Aerospace
    $GE
    4/1/2026$325.00Overweight
    Wells Fargo
    GE Aerospace
    $GE
    3/31/2026$301.00Neutral
    Daiwa Securities
    GE Aerospace
    $GE
    2/20/2026$425.00Overweight
    Morgan Stanley
    GE Aerospace
    $GE
    12/12/2025$386.00Buy
    Citigroup
    McKesson Corporation
    $MCK
    12/9/2025$960.00Overweight
    Barclays
    GE Aerospace
    $GE
    12/4/2025$350.00Positive
    Susquehanna
    More analyst ratings

    $CERN
    $GE
    $MCK
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Seaport Research Partners initiated coverage on GE Aerospace with a new price target

    Seaport Research Partners initiated coverage of GE Aerospace with a rating of Buy and set a new price target of $375.00

    5/27/26 9:01:57 AM ET
    $GE
    Consumer Electronics/Appliances
    Technology

    William Blair initiated coverage on McKesson

    William Blair initiated coverage of McKesson with a rating of Outperform

    4/28/26 7:45:38 AM ET
    $MCK
    Other Pharmaceuticals
    Health Care

    Wells Fargo initiated coverage on GE Aerospace with a new price target

    Wells Fargo initiated coverage of GE Aerospace with a rating of Overweight and set a new price target of $325.00

    4/1/26 8:37:20 AM ET
    $GE
    Consumer Electronics/Appliances
    Technology

    $CERN
    $GE
    $MCK
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    GE Aerospace and Wolfspeed Collaborate to Accelerate High-Voltage Silicon Carbide (SiC) Adoption

    Announcement highlights: GE Aerospace and Wolfspeed enter into a Memorandum of Understanding (MOU) to accelerate the commercial readiness and market acceptance of high-voltage silicon carbide solutions MOU includes the supply of Wolfspeed's 10 kV MOSFET die and jointly determining standard high-voltage power module formats for commercial introduction. The scope of the MOU aligns with the United States Government's stated priorities of accelerating critical technologies for achieving faster time-to-power for strategic markets such as Artificial Intelligence. GE Aerospace (NYSE:GE) and Wolfspeed Inc. (NYSE:WOLF) today announced that they have entered into a Memorandum of Understan

    6/8/26 9:00:00 AM ET
    $GE
    $WOLF
    Consumer Electronics/Appliances
    Technology
    Semiconductors

    McKesson Closes Strategic Investment with Apollo Funds for Minority Interest in Medical-Surgical Solutions

      McKesson Corporation (NYSE:MCK) announced today the successful completion of the previously announced minority ownership interest investment from funds managed by affiliates of Apollo ("Apollo Funds") in McKesson's Medical-Surgical Solutions ("MMS") business on June 1, 2026. This transaction represents a key milestone in McKesson's intention to separate MMS into an independent, publicly traded company, and positions the business for long-term growth. Apollo Funds invested $1.25 billion in convertible preferred equity of MMS to acquire an approximately 13% interest in MMS. The transaction values MMS at approximately $13 billion total enterprise valuation. McKesson retains operating con

    6/2/26 8:00:00 AM ET
    $MCK
    Other Pharmaceuticals
    Health Care

    GE Aerospace Awarded U.S. Air Force Contract to Advance GE426 Engine for Autonomous Collaborative Platform

    Cincinnati, Ohio, May 19, 2026 (GLOBE NEWSWIRE) -- GE Aerospace (NYSE:GE) has been awarded a contract from the U.S. Air Force to complete the preliminary design review (PDR) for its new GE426 engine in support of the Air Force's medium thrust class Autonomous Collaborative Platform (ACP) effort. The GE426 is a next-generation propulsion system purpose-built for the medium-thrust-class ACP mission, delivering the performance, affordability and manufacturability required for uncrewed, autonomous combat aircraft. This award builds on GE Aerospace's previously demonstrated capability to rapidly design, manufacture and test small engines in support of the Air Force's opportunities. In A

    5/19/26 12:08:33 PM ET
    $GE
    Consumer Electronics/Appliances
    Technology

    $CERN
    $GE
    $MCK
    SEC Filings

    View All

    SEC Form SD filed by GE Aerospace

    SD - GENERAL ELECTRIC CO (0000040545) (Filer)

    5/29/26 7:42:05 AM ET
    $GE
    Consumer Electronics/Appliances
    Technology

    SEC Form SD filed by McKesson Corporation

    SD - MCKESSON CORP (0000927653) (Filer)

    5/28/26 8:05:50 AM ET
    $MCK
    Other Pharmaceuticals
    Health Care

    GE Aerospace filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Leadership Update

    8-K - GENERAL ELECTRIC CO (0000040545) (Filer)

    5/7/26 4:15:33 PM ET
    $GE
    Consumer Electronics/Appliances
    Technology

    $CERN
    $GE
    $MCK
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SVP, Controller & CAO Rutledge Napoleon B Jr sold $101,612 worth of shares (133 units at $764.00) as part of a pre-agreed trading plan, decreasing direct ownership by 17% to 632 units (SEC Form 4)

    4 - MCKESSON CORP (0000927653) (Issuer)

    6/8/26 2:54:29 PM ET
    $MCK
    Other Pharmaceuticals
    Health Care

    EVP, Chief Strategy & BDO Rodgers Thomas L sold $604,420 worth of shares (822 units at $735.30) as part of a pre-agreed trading plan, decreasing direct ownership by 27% to 2,268 units (SEC Form 4)

    4 - MCKESSON CORP (0000927653) (Issuer)

    6/3/26 11:00:51 AM ET
    $MCK
    Other Pharmaceuticals
    Health Care

    EVP & Chief HR Officer Smith Leann B sold $1,331,255 worth of shares (1,810 units at $735.50) as part of a pre-agreed trading plan, decreasing direct ownership by 27% to 4,798 units (SEC Form 4)

    4 - MCKESSON CORP (0000927653) (Issuer)

    6/2/26 3:27:57 PM ET
    $MCK
    Other Pharmaceuticals
    Health Care

    $CERN
    $GE
    $MCK
    Leadership Updates

    Live Leadership Updates

    View All

    Companies Unveiling Autonomous Defense System Amid Surge Toward $43 Billion Global Market

    Integrated AI system empowers forces to detect, decide, and deploy faster than traditional command structuresNEW YORK, March 30, 2026 /CNW/ -- Market News Updates News Commentary - Autonomous systems are transforming defense operations by enabling militaries to conduct missions with reduced human intervention, increased precision, and faster decision-making cycles. These systems include unmanned aerial vehicles (UAVs), ground robots, maritime platforms, and AI-enabled command systems that support intelligence, surveillance, reconnaissance (ISR), and combat roles. Their integration is largely driven by advancements in artificial intelligence, sensor fusion, and real-time data processing, allo

    3/30/26 8:45:00 AM ET
    $GE
    $KTOS
    $PDYN
    Consumer Electronics/Appliances
    Technology
    Military/Government/Technical
    Industrials

    McKesson Announces Planned CFO Transition

    Britt Vitalone announces retirement, Kenny Cheung named as successor McKesson Corporation (NYSE:MCK) today announced Britt Vitalone, Executive Vice President and Chief Financial Officer (CFO), has elected to retire after a successful and distinguished 20-year career with the company, including more than eight years as CFO. Looking ahead, Kenny Cheung will join McKesson as Executive Vice President and CFO, effective May 29, 2026. "Britt is an exceptional partner and leader. He has been instrumental in advancing the company's financial performance, engaging with shareholders, and instilling a culture of financial discipline," said Brian Tyler, Chief Executive Officer, McKesson Corporation

    3/5/26 8:10:00 AM ET
    $MCK
    Other Pharmaceuticals
    Health Care

    Lyric Appoints Halsey Wise as Chief Executive Officer

    Experienced Healthcare Technology Leader to Steer Next Phase of Growth Lyric, a leader in payment integrity AI and claims analytics for health plans, today announced the appointment of Halsey Wise as Chief Executive Officer, effective immediately. Mr. Wise, a member of Lyric's Board of Directors since 2022, succeeds Raj Ronanki, who has transitioned into an advisory role to support the company's continued success. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260108426844/en/Halsey Wise, CEO, Lyric "Having experienced Lyric's dynamic growth as a member of the Board, I am honored to join as CEO to propel our next chapter," sai

    1/8/26 8:00:00 AM ET
    $AZPN
    $INGR
    $CERN
    EDP Services
    Technology
    Packaged Foods
    Consumer Staples

    $CERN
    $GE
    $MCK
    Financials

    Live finance-specific insights

    View All

    McKesson Reports Fiscal 2026 Fourth Quarter and Full Year Results, Provides Fiscal 2027 Guidance, and Reaffirms Long-Term Financial Growth Targets

    McKesson Corporation (NYSE:MCK) has released its fiscal 2026 fourth quarter financial results. Results can be accessed on McKesson's Investor Relations website at investor.mckesson.com/financials/quarterly-results. As previously announced, the company will host a live webcast of the earnings conference call for investors today, Thursday, May 7, at 4:30 PM ET to review its financial results. The audio webcast of the conference call will be available live and archived on McKesson's Investor Relations website, along with the company's earnings press release, financial tables, and slide presentation. Additional information about upcoming events for the investor community can be found at inves

    5/7/26 4:10:00 PM ET
    $MCK
    Other Pharmaceuticals
    Health Care

    McKesson Corporation Declares Quarterly Dividend

    The Board of Directors of McKesson Corporation (NYSE:MCK) yesterday declared a regular dividend of 82 cents per share of common stock. The dividend will be payable on July 1, 2026, to shareholders of record on June 1, 2026. About McKesson Corporation McKesson Corporation is a diversified healthcare services leader dedicated to advancing health outcomes for patients everywhere. Our teams partner with biopharma companies, care providers, pharmacies, manufacturers, governments, and others to deliver insights, products and services to help make quality care more accessible and affordable. Learn more about how McKesson is impacting virtually every aspect of healthcare at McKesson.com and rea

    4/22/26 8:00:00 AM ET
    $MCK
    Other Pharmaceuticals
    Health Care

    McKesson Corporation Announces Fourth Quarter Fiscal 2026 Earnings Release Date and Participation in Upcoming Conferences

    McKesson Corporation (NYSE:MCK) will release its fourth quarter fiscal 2026 financial results after market close on Thursday, May 7, 2026. Chief Executive Officer Brian Tyler and Chief Financial Officer Britt Vitalone will host a live webcast of the earnings conference call for investors at 4:30 PM Eastern Time to review its financial results. Mr. Vitalone will be participating in Leerink Partners Global Healthcare Conference and Barclays Global Healthcare Conference on Wednesday, March 11, 2026. Mr. Vitalone will also participate in the BofA Securities 2026 Healthcare Conference in May 2026. McKesson Corporation has reaffirmed fiscal 2026 full year outlook as previously issued on Febru

    3/6/26 8:00:00 AM ET
    $MCK
    Other Pharmaceuticals
    Health Care

    $CERN
    $GE
    $MCK
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by GE Aerospace

    SC 13G/A - GENERAL ELECTRIC CO (0000040545) (Subject)

    11/12/24 12:54:20 PM ET
    $GE
    Consumer Electronics/Appliances
    Technology

    SEC Form SC 13G/A filed by McKesson Corporation (Amendment)

    SC 13G/A - MCKESSON CORP (0000927653) (Subject)

    2/13/24 5:09:38 PM ET
    $MCK
    Other Pharmaceuticals
    Health Care

    SEC Form SC 13G/A filed by General Electric Company (Amendment)

    SC 13G/A - GENERAL ELECTRIC CO (0000040545) (Subject)

    2/13/24 4:55:49 PM ET
    $GE
    Consumer Electronics/Appliances
    Technology